Helogen
01What it doesHelogen builds automated space factories to make advanced biomaterials for medical implants.Source-grounded · automated review · Explore ↗
Checked 2026-09-06 · Review due 2026-09-13
Read supporting source ↗Helogen is a space infrastructure…
02Who is involvedEvidence still neededOpen review status ↗
Supported as a rejection of Series A investor claims. The documents identify seed/to-date investors including RRE Ventures, Oceans, One Way Ventures, Blisce, AUM, Aurelia Foundry, Mana VC and angels, but do not identify investors in an announced Series A. Document 1 says the company is now building
03What happenedEvidence still neededOpen review status ↗
Supported. The target says Series A dated 2026-09-04, but the supplied financing event on 2026-09-04 is $7.1m seed funding, not Series A. Document 1 states Helogen has raised $7.9 million to date and is building toward its Series A, so an announced Series A is not established.
04Why it mattersIts October missions aim to test medical-grade production of biomaterials made in orbit.Interpretation · Explore ↗
Helogen · Financing Record
Explore source-linked visual explanations for Helogen. Unsupported claims are withheld while source review continues.
Record 11649 · Recorded date: 2026-09-04
Explore company records →